Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial
Ingo Fietze, Claudio L. Bassetti, David Mayleben, et al.
Drugs & Aging (2022) Vol. 39, Iss. 10, pp. 795-810
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Insomnia Management: A Review and Update
David Shaha
The Journal of Family Practice (2023) Vol. 72, Iss. 06 Supp
Open Access | Times Cited: 29
Chronic Insomnia Disorder across Europe: Expert Opinion on Challenges and Opportunities to Improve Care
Jason Ellis, Luigi Ferini‐Strambi, Diego García‐Borreguero, et al.
Healthcare (2023) Vol. 11, Iss. 5, pp. 716-716
Open Access | Times Cited: 17
Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease
J Kron, Ryan J. Keenan, Daniël Hoyer, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 359-386
Open Access | Times Cited: 15
Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus Group
Laura Palagini, Raffaele Manni, Claudio Liguori, et al.
Journal of Neurology (2023) Vol. 271, Iss. 4, pp. 1668-1679
Closed Access | Times Cited: 13
Orexinergic Receptor Antagonists as a New Therapeutic Target to Overcome Limitations of Current Pharmacological Treatment of Insomnia Disorder
Cecilio Álamo, Jerónimo Sáiz Ruiz, Cristina Zaragozá Arnáez
Actas Españolas de Psiquiatría (2024) Vol. 52, Iss. 2, pp. 172-182
Open Access | Times Cited: 5
Effects of daridorexant on rest/wake activity patterns and drinking in adult rats exposed to chronic ethanol vapor in adolescence
Leslie R. Amodeo, Derek N. Wills, Jason Benedict, et al.
Alcohol (2025)
Open Access
Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Comparison of efficacy and safety of dual orexin receptor antagonists lemborexant and daridorexant for the treatment of insomnia: a systematic review and meta-analysis
Ming Tang, Ziyi Shen, Peilu Yu, et al.
Psychopharmacology (2025)
Closed Access
2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults – Brazilian Sleep Association
Luciano F. Drager, Márcia Assis, Andrea Bacelar, et al.
Sleep Science (2023) Vol. 16, Iss. S 02, pp. 507-549
Open Access | Times Cited: 9
Daridorexant in Insomnia Disorder: A Profile of Its Use
Tina Nie, Hannah A. Blair
CNS Drugs (2023) Vol. 37, Iss. 3, pp. 267-274
Open Access | Times Cited: 8
Sleep disorders in Lewy body dementia: Mechanisms, clinical relevance, and unanswered questions
Leigh Townsend, Kirstie N. Anderson, Bradley F. Boeve, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 5264-5283
Open Access | Times Cited: 8
Current and Emerging Sleep Interventions for Older Adults with or without Mild Cognitive Impairment
Anastasia Suraev, Shawn Dexiao Kong, Zoe Menczel Schrire, et al.
Current Treatment Options in Neurology (2024) Vol. 26, Iss. 11, pp. 463-483
Open Access | Times Cited: 2
Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
Tao Xue, Xin Wu, Jiaxuan Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Daridorexant: Comprehensive Review of A New Oral Agent for the Treatment of Insomnia
Juliane Park, Kandon P. Render, Drew W. Cates
Annals of Pharmacotherapy (2023) Vol. 57, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 5
A Comprehensive Review of Novel FDA-Approved Psychiatric Medications (2018-2022)
Shannon Giliberto, Rhea Shishodia, Meredith Nastruz, et al.
Cureus (2024)
Open Access | Times Cited: 1
Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer’s Disease and Associated Sleep Disorders
Matteo Carpi, Nicola Biagio Mercuri, Claudio Liguori
Drugs (2024)
Open Access | Times Cited: 1
Daridorexant for patients with chronic insomnia disorder: number needed to treat, number needed to harm, and likelihood to be helped or harmed
François-Xavier Chalet, Pierre‐Philippe Luyet, Cristina Rabasa, et al.
Postgraduate Medicine (2024) Vol. 136, Iss. 4, pp. 396-405
Open Access | Times Cited: 1
Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: Results from phase 1 and 2 studies
Makoto Uchiyama, Kazuo Mishima, Tomoko Yagi, et al.
Journal of Sleep Research (2024)
Open Access | Times Cited: 1
Daridorexant as a novel pharmacotherapeutic approach in insomnia: a systematic review and meta-analysis
Siddhartha Dutta, Shubha Singhal, Rima Shah, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 12, pp. 1237-1251
Open Access | Times Cited: 3
Daridorexant, an Orexin Receptor Antagonist for the Management of Insomnia
Jadwiga Najib, Yuliana Toderika, Lorena Dima
American Journal of Therapeutics (2023) Vol. 30, Iss. 4, pp. e360-e368
Closed Access | Times Cited: 3
Schlafstörungen bei Demenzerkrankungen
Moritz Brandt
Springer eBooks (2024), pp. 47-69
Closed Access
A comprehensive review of Dual Orexin Receptor Antagonist (DORA), Daridorexant: Novel drug for sleep and related disorders
Saurav Misra, Manmeet Kaur, Jayant Kumar Kairi
International journal of life sciences, biotechnology and pharma research. (2024) Vol. 13, Iss. 6, pp. 20-29
Open Access
Dose-response of daridorexant in insomnia disorder: An analysis of Phase 2 and 3 studies
Pierre‐Philippe Luyet, W. Vaughn McCall, Claudio L. Bassetti, et al.
Sleep Medicine (2024) Vol. 121, pp. 315-325
Open Access
Updated Insomnia Guidelines and Latest Real-World Evidence Data on Daridorexant
S R Coates
EMJ Neurology (2024), pp. 42-50
Open Access
Page 1 - Next Page

Scroll to top